EBS Earnings Emergent BioSolutions Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | 0.07 | 2026-05-01 | 10-Q |
| FY 2025 | 2025-12-31 | 0.93 | 2026-02-27 | 10-K |
| Q3 2025 | 2025-09-30 | 1.89 | 2025-10-30 | 10-Q |
| Q2 2025 | 2025-06-30 | 0.99 | 2025-08-07 | 10-Q |
| Q1 2026 | 2025-03-31 | 1.19 | 2026-05-01 | 10-Q |
| FY 2025 | 2024-12-31 | -3.60 | 2026-02-27 | 10-K |
| Q3 2025 | 2024-09-30 | -3.03 | 2025-10-30 | 10-Q |
| Q2 2025 | 2024-06-30 | -5.23 | 2025-08-07 | 10-Q |
| Q1 2025 | 2024-03-31 | 0.17 | 2025-05-08 | 10-Q |
| FY 2025 | 2023-12-31 | -14.85 | 2026-02-27 | 10-K |
| Q3 2024 | 2023-09-30 | -13.97 | 2024-11-07 | 10-Q |
| Q2 2024 | 2023-06-30 | -8.86 | 2024-08-07 | 10-Q |
| Q1 2024 | 2023-03-31 | -3.71 | 2024-05-02 | 10-Q |
| FY 2024 | 2022-12-31 | -4.22 | 2025-03-04 | 10-K |
| Q3 2023 | 2022-09-30 | -2.88 | 2023-12-11 | 10-Q |
| Q3 2023 | 2022-06-30 | -1.06 | 2023-12-11 | 10-Q |
| Q3 2023 | 2022-03-31 | -0.09 | 2023-12-11 | 10-Q |
| FY 2023 | 2021-12-31 | 4.06 | 2024-03-08 | 10-K |
| Q3 2022 | 2021-09-30 | 0.77 | 2022-11-09 | 10-Q |
| Q2 2022 | 2021-06-30 | 1.37 | 2022-08-02 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.